Globus Medical Inc
Change company Symbol lookup
Select an option...
GMED Globus Medical Inc
WMT WALMART STORES INC
DX Dynex Capital Inc
BMO Bank of Montreal
FPRX Five Prime Therapeutics Inc
VTR Ventas Inc
PENN Penn National Gaming Inc
SUN Sunoco LP
SWKS Skyworks Solutions Inc
VOO Vanguard S&P 500 ETF
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profile

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque. The Company's portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques.

Closing Price
$53.74
Day's Change
-1.06 (-1.93%)
Bid
--
Ask
--
B/A Size
--
Day's High
54.71
Day's Low
53.26
Volume
(Average)
Volume:
559,650

10-day average volume:
607,687
559,650

IQiyi's stock plunges on heavy volume after SEC probe disclosure, weighs on Baidu shares

2:39 pm ET August 14, 2020 (MarketWatch)
Print

Shares of iQiyi Inc. (IQ) plunged 15% on heavy volume Friday, in the wake of the China-based streaming video service's disclosure of an investigation by the Securities and Exchange Commission related to certain acquisitions and investments. Trading volume was 38.5 million shares, enough to make the stock the 7th-most actively traded on major U.S. exchanges, and more than 7-times the full-day average. The SEC investigation follows a report issued by short seller Wolfpack Research in April. Analyst Rob Sanderson at Loop Capital Markets said said investors "should not be incrementally rattled by the announcement of the SEC investigation," as the lack of content and heavy post-COVID-19 attrition was already well known. The disclosure of the investigation was in the company's second-quarter earnings report out late Thursday (http://www.marketwatch.com/story/ke-holdings-shares-are-off-to-a-flying-start-in-ipo-debut-that-raises-212-billion-2020-08-13), in which iQiyi reported a narrower-than-expected loss and revenue that rose more than forecasts, according to FactSet, while online ad revenue and subscribers missed, Loop's Sanderson said. Separately, the stock's selloff was helping knock Baidu Inc.'s stock (K3SD.SG) down 6.1%. In Baidu's second-quarter report, the China-based internet search and marketing company said revenue iQiyi represented about 27% of total revenue. Year to date, shares of iQiyi have shed 12.4% and Baidu have lost 7.5%, while the iShares MSCI China ETF (MCHI) has rallied 12.6% and the S&P 500 has gained 4.5%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

August 14, 2020 14:39 ET (18:39 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.